Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
Numerous randomized trials have compared intravascular imaging-guided PCI with angiography-guided PCI. However, most of these prior trials have used intravascular ultrasound . Optical coherence tomography is a newer intravascular imaging modality that has enhanced resolution compared to IVUS.
The analysis incorporated 20 randomized trials of intravascular imaging-guided PCI compared with angiography-guided PCI in 12,428 patients with chronic and acute coronary syndromes. Of those, 7,038 were randomly allocated to intravascular imaging guidance , and 5,390 patients were randomly allocated to angiography guidance. Patients were followed for between 6 months and 5 years.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Intravascular imaging associated with improved outcomes compared with angiographyIntravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session August 27 at ESC Congress 2023.
Read more »
Optical coherence tomography for stent insertion in complex cases shows mixed efficacyOptical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session August 27 at ESC Congress 2023. Stent thrombosis was significantly reduced with OCT-guided PCI.
Read more »
Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent eraPrasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
Read more »
Optical coherence tomography shown to improve stent implantation outcomes in bifurcation lesionsPercutaneous coronary intervention (PCI) guided by optical coherence tomography (OCT) reduces adverse cardiac events in patients with bifurcation lesions, according to late breaking research presented in a Hot Line session August 27 at ESC Congress 2023.
Read more »